Tixentamig
Tixentamig is a bispecific monoclonal antibody targeting human CD3 ε and CLDN18 (claudin 18) . Tixentamig is promising for research of cancers[1].
Product Specifications
CAS Number
2969220-04-8
UNSPSC
12352203
Target
CD3; Claudin
Related Pathways
Cytoskeleton; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Tixentamig]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CLDN18
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog